Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amino Capital is an active Palo Alto-based global venture capital firm investing in seed to growth-stage startups, with emphasis on data-driven networks and "data-moat" technology. Investments span consumer tech, fintech, PLG SaaS, frontier tech, AI, Web3, and some health tech; portfolio includes more than 200 companies and over $1 billion managed, with 25 successful exits and 17 unicorns. Not an operating healthcare/biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amino Capital.